Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Sears, David ^a   Kigozi, Ruth ^b   Mpimbaza, Arthur ^b,c   Kakeeto, Stella ^b   Sserwanga, Asadu ^b   Staedke, Sarah G ^d   Chang, Michelle ^e   Kapella, Bryan K ^e   Rubahika, Denis ^f   Kamya, Moses R ^b,g   Dorsey, Grant ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Uganda Malaria Surveillance Project   (Uganda)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f MINISTRY OF HEALTH   (Uganda)

^g MAKERERE UNIVERSITY   (Uganda)

Author keywords

Anti malarial; Artemether lumefantrine; Artemisinin based combination therapy; Case management; Malaria; Outpatient; Plasmodium falciparum; Prescription; Treatment

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; QUININE;

ARTICLE; BODY WEIGHT; CASE MANAGEMENT; CLINICAL PRACTICE; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL EDUCATION; MONOTHERAPY; OUTPATIENT CARE; PRESCRIPTION; PUBLIC HEALTH SERVICE;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT; LACTONES; MALARIA; MALE; MIDDLE AGED; OUTPATIENTS; PREGNANCY; PRESCRIPTIONS; UGANDA; YOUNG ADULT;

EID: 84880335109     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-252     Document Type: Article

References (36)

1. WHO, Antimalarial drug combination therapy: report of a WHO technical consultation Geneva, Switzerland: World Health Organization 2001
2. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Bosman A, Mendis KN, Am J Trop Med Hyg 2007 77 193 197 18165492
3. WHO, Guidelines for the Treatment of Malaria (Second Edition) Geneva, Switzerland: World Health Organization 2010
4. Malaria Case-Management following Change of Policy to Universal Parasitological Diagnosis and Targeted Artemisinin-Based Combination Therapy in Kenya. Nyandigisi A, Memusi D, Mbithi A, Ang'wa N, Shieshia M, Muturi A, Sudoi R, Githinji S, Juma E, Zurovac D, Plos One 2011 6 24781 10.1371/journal.pone. 0024781 21935464
5. Variation in malaria transmission intensity in seven sites throughout Uganda. Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P, Talisuna A, D' Alessandro U, Coosemans M, Am J Trop Med Hyg 2006 75 219 225 16896122 (Pubitemid 46941334)
6. WHO, World Malaria Report 2012 Geneva, Switzerland: World Health Organization 2012
7. Malaria treatment policy change and implementation: the case of Uganda. Nanyunja M, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J, Malar Res Treat 2011 2011 1 14
8. National Policy on Malaria Treatment 2005 http://www.health.go.ug/mcp/ NationalPolicyonMalariaTreatment(07-03-06).pdf
9. Uganda Malaria Control Strategic Plan 2005/06-2009/10 http://www.rbm.who.int/countryaction/nsp/uganda.pdf
10. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW, Malar J 2008 7 181 10.1186/1475-2875-7-181 18803833
11. Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda. Sserwanga A, Harris JC, Kigozi R, Menon M, Bukirwa H, Gasasira A, Kakeeto S, Kizito F, Quinto E, Rubahika D, Nasr S, Filler S, Kamya MR, Dorsey G, PLoS One 2011 6 16316 10.1371/journal.pone.0016316 21283815
12. Indoor Residual Spraying of Insecticide and Malaria Morbidity in a High Transmission Intensity Area of Uganda. Kigozi R, Baxi SM, Gasasira A, Sserwanga A, Kakeeto S, Nasr S, Rubahika D, Dissanayake G, Kamya MR, Filler S, Dorsey G, PLoS One 2012 7 42857 10.1371/journal.pone.0042857 22880123
13. President's Malaria Initiative, Presiden't Malaria Initiative Uganda Malaria Operational Plan FY 2013 Washington, DC, USA 2012
14. Improved malaria case management after integrated team-based training of health care workers in Uganda. Ssekabira U, Bukirwa H, Hopkins H, Namagembe A, Weaver MR, Sebuyira LM, Quick L, Staedke S, Yeka A, Kiggundu M, Schneider G, McAdam K, Wabwire-Mangen F, Dorsey G, Am J Trop Med Hyg 2008 79 826 833 19052287
15. Improved clinical and laboratory skills after team-based, malaria case management training of health professionals in Uganda. Namagembe A, Ssekabira U, Weaver MR, Blum N, Burnett S, Dorsey G, Mpanga-Sebuyira L, Ojaku A, Schneider G, Willis K, Malar J 2012 11 44 10.1186/1475-2875-11-44 22330281
16. Combination therapy for uncomplicated falciparum malaria in Ugandan children. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
17. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, PLos Clin Trials 2007 2 20 10.1371/journal.pctr.0020020 17525792 (Pubitemid 46860146)
18. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H, PLoS ONE 2008 3 2390 10.1371/journal.pone.0002390 18545692
19. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Achan J, Tibenderana JK, Kyabayinze D, Mangen FW, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO, BMJ 2009 339 2763 10.1136/bmj.b2763 19622553
20. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Clin Infect Dis 2009 49 1629 1637 10.1086/647946 19877969
21. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Nsobya SL, Kiggundu M, Nanyunja S, Joloba M, Greenhouse B, Rosenthal PJ, Antimicrob Agents Chemother 2010 54 1200 1206 10.1128/AAC.01412-09 20065051
22. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW, BMJ 2005 331 734 10.1136/bmj.331.7519.734 16195289
23. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW, Malar J 2007 6 31 10.1186/1475-2875-6-31 17367518 (Pubitemid 46482315)
24. Improved diagnostic testing and malaria treatment practices in Zambia. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, Sipilinyambe N, Simon JL, Snow RW, JAMA 2007 297 2227 2231 10.1001/jama.297.20.2227 17519412 (Pubitemid 47010880)
25. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW, Trop Med Int Health 2008 13 99 107 10.1111/j.1365-3156. 2007.01980.x 18291008 (Pubitemid 351271396)
26. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin- combination therapy. Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D, Malar J 2009 8 2 10.1186/1475-2875-8-2 19123926
27. Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005. Thwing JI, Njau JD, Goodman C, Munkondya J, Kahigwa E, Bloland PB, Mkikima S, Mills A, Abdulla S, Kachur SP, Trop Med Int Health 2011 16 272 279 10.1111/j.1365-3156. 2010.02724.x 21226795
28. Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon. Mangham LJ, Cundill B, Achonduh OA, Ambebila JN, Lele AK, Metoh TN, Ndive SN, Ndong IC, Nguela RL, Nji AM, Trop Med Int Health 2011 17 330 342 22098135
29. Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey. Abdelgader TM, Ibrahim AM, Elmardi KA, Githinji S, Zurovac D, Snow RW, Noor AM, BMC Public Health 2012 12 11 10.1186/1471-2458-12-11 22221821
30. Taking stock: provider prescribing practices in the presence and absence of ACT stock. Hensen B, Paintain LS, Shretta R, Bruce J, Jones C, Webster J, Malar J 2011 10 218 10.1186/1475-2875-10-218 21812948
31. Prescribing practices for malaria in a rural Ugandan hospital: evaluation of a new malaria treatment policy. Ucakacon PS, Achan J, Kutyabam P, Odoi AR, Kalyango NJ, Afr Health Sci 2011 11 53 59
32. Uganda Bureau of Statistics (UBOS), ICF International Inc, Uganda Demographic and Health Survey 2011 Kampala, Uganda and Calverton, Maryland: UBOS and ICF International Inc 2012
33. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Malar J 2011 10 327 10.1186/1475-2875-10-327 22039892
34. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP, Am J Trop Med Hyg 2004 71 525 530 15569777 (Pubitemid 39601144)
35. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann J-P, Lancet 2005 365 1467 1473 10.1016/S0140-6736(05)66416-1 15850630 (Pubitemid 40591691)
36. Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda. Cohen JL, Yavuz E, Morris A, Arkedis J, Sabot O, Malar J 2012 11 83 10.1186/1475-2875-11-83 22443291